Overview

The Response to Atropine Drops (RAD) Study

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the comfort of giving low concentration atropine eye drops.
Phase:
Early Phase 1
Details
Lead Sponsor:
Ohio State University
Treatments:
Atropine